Grant: Engage Grants Program
University of Waterloo
$25,000.00
Investigating the mechanisms of small molecule separation in blood plasma
FY 2017-18
Summary
One of the key functions of kidneys is to separate uremic toxins from the blood. Currently, dialysis is the maintechnique of separation of uremic toxins from blood. In this regard, End Stage Renal Disease (ESRD) is aglobal health concern with a high prevalence percentage (15% - global; 30% - Canada). The leading treatmentfor ESRD patients is hemodialysis, where the blood is passed through a semipermeable membrane and theuremic toxins diffuse into the dialysate. This is a repetitive, laborious, time consuming and expensive process.Qidni Labs Inc., Kitchener, Ontario is developing renal replacement therapies that will eliminate the necessityof dialysis clinic sessions and will administer continuous and automatic renal therapy. In this proposal QidniLabs Inc. and Dr. Praveen Nekkar Rao (Associate Professor, School of Pharmacy, University of Waterloo) arecollaborating to investigate alternative methods of separating uremic toxins using a novel microfluidic platformand their detection using analytical tools. This proposal aims to investigate novel methods of separating uremictoxins using a novel microfluidic platform and their detection using analytical tools. The outcomes areanticipated to reveal the mechanisms of small molecule separation using the microfluidic technology and theirpotential application to kidney patients in Canada thereby providing health and economic benefits toCanadians.
Program
Engage Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
515793-2017
Name nom
NekkarRao, Praveen
Department département
Pharmacy, School of
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2100
Research subject group en
Mechanical engineering
Research subject group fr
Génie mécanique
Research subject en
Mechanical engineering
Research subject fr
Génie mécanique
Partie
1
Nb partie
1
Application title
Investigating the mechanisms of small molecule separation in blood plasma
Keyword
NSERC
Application summary
One of the key functions of kidneys is to separate uremic toxins from the blood. Currently, dialysis is the maintechnique of separation of uremic toxins from blood. In this regard, End Stage Renal Disease (ESRD) is aglobal health concern with a high prevalence percentage (15% - global; 30% - Canada). The leading treatmentfor ESRD patients is hemodialysis, where the blood is passed through a semipermeable membrane and theuremic toxins diffuse into the dialysate. This is a repetitive, laborious, time consuming and expensive process.Qidni Labs Inc., Kitchener, Ontario is developing renal replacement therapies that will eliminate the necessityof dialysis clinic sessions and will administer continuous and automatic renal therapy. In this proposal QidniLabs Inc. and Dr. Praveen Nekkar Rao (Associate Professor, School of Pharmacy, University of Waterloo) arecollaborating to investigate alternative methods of separating uremic toxins using a novel microfluidic platformand their detection using analytical tools. This proposal aims to investigate novel methods of separating uremictoxins using a novel microfluidic platform and their detection using analytical tools. The outcomes areanticipated to reveal the mechanisms of small molecule separation using the microfluidic technology and theirpotential application to kidney patients in Canada thereby providing health and economic benefits toCanadians.